Brian P. Kennedy

Mechanism of Inhibition of Protein-tyrosine Phosphatases by Vanadate and Pervanadate

Gregory Huyer, Susana Liu, John A. Kelly et al. · Journal of Biological Chemistry · 1997 · 827 citations · Full text

Life Sciences, Biochemistry, Pharmacology +15

Attenuation of Leptin Action and Regulation of Obesity by Protein Tyrosine Phosphatase 1B

Alan Cheng, Noriko Uetani, Paul D. Simoncic et al. · Developmental Cell · 2002 · 546 citations · Full text

Life Sciences, Endocrinology, Physiology +14

Thermodynamic Constraints on Nitrogen Transformations and Other Biogeochemical Processes at Soil-Stream Interfaces

Lars O. Hedin, Joseph C. von Fischer, Nathaniel E. Ostrom et al. · Ecology · 1998 · 470 citations

Natural Sciences, Earth Sciences, Hydrology +15

The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor

Petpiboon Prasit, Z Wang, Christine Brideau et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 429 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Rofecoxib [Vioxx, MK-0966; 4-(4′-Methylsulfonylphenyl)-3-phenyl-2-(5 H)-furanone]: A Potent and Orally Active Cyclooxygenase-2 Inhibitor. Pharmacological and Biochemical Profiles

Chi‐Chung Chan, S. Boyce, Christine Brideau et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 399 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15